• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用肥胖诱导多能干细胞-肝细胞分化进行肝发生的发育建模揭示了病理特征。

Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features.

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, United Arab Emirates.

Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, United Arab Emirates.

出版信息

Cell Death Dis. 2022 Aug 1;13(8):670. doi: 10.1038/s41419-022-05125-9.

DOI:10.1038/s41419-022-05125-9
PMID:35915082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9343434/
Abstract

Obesity is a multigene disorder. However, in addition to genetic factors, environmental determinants also participate in developing obesity and related pathologies. Thus, obesity could be best described as a combination of genetic and environmental perturbations often having its origin during the early developmental period. Environmental factors such as energy-dense food and sedentary lifestyle are known to be associated with obesogenicity. However, the combinatorial effects of gene-environment interactions are not well understood. Understanding the role of multiple genetic variations leading to subtle gene expression changes is not practically possible in monogenic or high-fat-fed animal models of obesity. In contrast, human induced pluripotent stem cells (hiPSCs) from individuals with familial obesity or an obesogenic genotype could serve as a good model system. Herein, we have used hiPSCs generated from normal and genetically obese subjects and differentiated them into hepatocytes in cell culture. We show that hepatocytes from obese iPSCs store more lipids and show increased cell death than normal iPSCs. Whole transcriptome analyses in both normal and obese iPSCs treated with palmitate compared to control revealed LXR-RXR and hepatic fibrosis pathways were enriched among other pathways in obese iPSCs compared to normal iPSCs. Among other genes, increased CD36 and CAV1 expression and decreased expression of CES1 in obese iPSCs could have been responsible for excess lipid accumulation, resulting in differential expression of genes associated with hepatic fibrosis, a key feature of non-alcoholic fatty liver disease (NAFLD). Our results demonstrate that iPSCs derived from genetically obese subjects could serve as an excellent model to understand the effects of this multigene disorder on organ development and may uncover pathologies of NAFLD, which is highly associated with obesity.

摘要

肥胖是一种多基因疾病。然而,除了遗传因素外,环境决定因素也参与了肥胖症和相关病理的发生。因此,肥胖症最好被描述为遗传和环境干扰的组合,这些干扰通常起源于早期发育阶段。已知高热量食物和久坐不动的生活方式等环境因素与肥胖有关。然而,基因-环境相互作用的组合效应尚未得到很好的理解。在单基因或高脂肪喂养的肥胖动物模型中,理解导致细微基因表达变化的多种遗传变异的作用在实践上是不可能的。相比之下,来自家族性肥胖或肥胖基因型个体的人诱导多能干细胞(hiPSC)可以作为一个很好的模型系统。在此,我们使用来自正常和遗传肥胖个体的 hiPSC 并在细胞培养中将其分化为肝细胞。我们表明,来自肥胖 hiPSC 的肝细胞储存更多的脂质,并且比正常 hiPSC 表现出更多的细胞死亡。与对照组相比,用棕榈酸处理的正常和肥胖 hiPSC 的全转录组分析显示,与正常 hiPSC 相比,肥胖 hiPSC 中 LXR-RXR 和肝纤维化途径以及其他途径更为丰富。在其他基因中,肥胖 hiPSC 中 CD36 和 CAV1 表达增加和 CES1 表达降低可能导致脂质过度积累,导致与肝纤维化相关的基因表达差异,肝纤维化是非酒精性脂肪性肝病(NAFLD)的一个关键特征。我们的结果表明,来自遗传肥胖个体的 hiPSC 可以作为一个很好的模型来理解这种多基因疾病对器官发育的影响,并可能揭示与肥胖高度相关的 NAFLD 的病理学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/b6fc8938bece/41419_2022_5125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/47f9c22a29d7/41419_2022_5125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/c547ca19b733/41419_2022_5125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/b2824161a9e6/41419_2022_5125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/3cd024159725/41419_2022_5125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/7e48d53b3dd9/41419_2022_5125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/7b7851e02124/41419_2022_5125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/b6fc8938bece/41419_2022_5125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/47f9c22a29d7/41419_2022_5125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/c547ca19b733/41419_2022_5125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/b2824161a9e6/41419_2022_5125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/3cd024159725/41419_2022_5125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/7e48d53b3dd9/41419_2022_5125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/7b7851e02124/41419_2022_5125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f32/9343434/b6fc8938bece/41419_2022_5125_Fig7_HTML.jpg

相似文献

1
Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features.使用肥胖诱导多能干细胞-肝细胞分化进行肝发生的发育建模揭示了病理特征。
Cell Death Dis. 2022 Aug 1;13(8):670. doi: 10.1038/s41419-022-05125-9.
2
The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease.海洋化合物和延伸因子 1A1 抑制剂,didemnin B,在西方饮食诱导的非酒精性脂肪肝病中提供益处。
Pharmacol Res. 2020 Nov;161:105208. doi: 10.1016/j.phrs.2020.105208. Epub 2020 Sep 22.
3
Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.肝活检衍生的诱导多能干细胞为生成肝样细胞提供了无限的供应。
PLoS One. 2019 Aug 29;14(8):e0221762. doi: 10.1371/journal.pone.0221762. eCollection 2019.
4
Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells.肝谱系阶段特异性供体记忆对诱导性小鼠多能干细胞的差异潜能的贡献。
Stem Cells. 2012 May;30(5):997-1007. doi: 10.1002/stem.1074.
5
Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.肝细胞窖蛋白-1调节非酒精性脂肪性肝病的代谢基因谱和功能。
Cell Death Dis. 2020 Feb 6;11(2):104. doi: 10.1038/s41419-020-2295-5.
6
Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.在患有非酒精性脂肪性肝病(NAFLD)的肥胖受试者中,脂质代谢降低但脂肪酸生物合成增加与肝脏微小RNA的变化相关。
Int J Obes (Lond). 2017 Apr;41(4):620-630. doi: 10.1038/ijo.2017.21. Epub 2017 Jan 25.
7
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
8
Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.长链脂肪酸通过 CD36 介导的氧化应激激活肝细胞。
Lipids Health Dis. 2018 Jul 17;17(1):153. doi: 10.1186/s12944-018-0790-9.
9
A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.内质网应激诱导脂肪变性建立的人诱导多能干细胞源性肝细胞非酒精性脂肪性肝病模型。
Dis Model Mech. 2018 Sep 25;11(9):dmm033530. doi: 10.1242/dmm.033530.
10
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.患者特异性诱导多能干细胞来源的肝细胞样细胞的脂质组学分析。
Dis Model Mech. 2017 Sep 1;10(9):1141-1153. doi: 10.1242/dmm.030841. Epub 2017 Jul 21.

引用本文的文献

1
Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review.用于疾病建模和胰岛素抵抗治疗中胰岛素靶细胞再生的人诱导多能干细胞(iPSC):综述
Cells. 2025 Aug 1;14(15):1188. doi: 10.3390/cells14151188.
2
Characteristics of chemically induced liver progenitors derived from a pig model of metabolic dysfunction-associated steatotic liver disease.源自代谢功能障碍相关脂肪性肝病猪模型的化学诱导肝祖细胞的特征
PLoS One. 2024 Dec 5;19(12):e0313312. doi: 10.1371/journal.pone.0313312. eCollection 2024.
3
A Study on iPSC-Associated Factors in the Generation of Hepatocytes.

本文引用的文献

1
P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation.P300/CBP相关因子通过SMAD2乙酰化激活心脏成纤维细胞。
Int J Mol Sci. 2021 Sep 14;22(18):9944. doi: 10.3390/ijms22189944.
2
The genetics of obesity: from discovery to biology.肥胖的遗传学:从发现到生物学。
Nat Rev Genet. 2022 Feb;23(2):120-133. doi: 10.1038/s41576-021-00414-z. Epub 2021 Sep 23.
3
Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease.遗传易感性、生活方式风险和肥胖与非酒精性脂肪性肝病的进展相关。
人诱导多能干细胞生成肝细胞相关因素的研究。
Tissue Eng Regen Med. 2024 Dec;21(8):1245-1254. doi: 10.1007/s13770-024-00674-w. Epub 2024 Nov 4.
4
Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC-Hepatocyte Culture.供体年龄和肝脂肪变性对脱细胞肝脏基质用作 iPSC 肝细胞培养平台的潜力的影响。
Adv Healthc Mater. 2024 May;13(13):e2302943. doi: 10.1002/adhm.202302943. Epub 2024 Feb 21.
Dig Liver Dis. 2021 Nov;53(11):1435-1442. doi: 10.1016/j.dld.2021.07.009. Epub 2021 Aug 1.
4
Copy number variation in the CES1 gene and the risk of non-alcoholic fatty liver in a Chinese Han population.中国汉族人群中CES1基因的拷贝数变异与非酒精性脂肪肝风险
Sci Rep. 2021 Jul 7;11(1):13984. doi: 10.1038/s41598-021-93549-2.
5
The Genetic Basis of Obesity and Related Metabolic Diseases in Humans and Companion Animals.人类和伴侣动物肥胖及相关代谢疾病的遗传基础。
Genes (Basel). 2020 Nov 20;11(11):1378. doi: 10.3390/genes11111378.
6
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms.小儿非酒精性脂肪肝疾病:营养起源与潜在分子机制。
Nutrients. 2020 Oct 16;12(10):3166. doi: 10.3390/nu12103166.
7
Developmental Programming of NAFLD by Parental Obesity.父母肥胖导致非酒精性脂肪性肝病的发育编程
Hepatol Commun. 2020 Aug 9;4(10):1392-1403. doi: 10.1002/hep4.1578. eCollection 2020 Oct.
8
Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions.非酒精性脂肪性肝病与2型糖尿病:一个解决方案尚不明确的新兴问题。
Hepatobiliary Surg Nutr. 2020 Aug;9(4):514-517. doi: 10.21037/hbsn.2019.11.28.
9
LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases.长链非编码RNA NEAT1:揭示肝脏疾病的机制与机遇
Liver Int. 2020 Nov;40(11):2612-2626. doi: 10.1111/liv.14629. Epub 2020 Oct 13.
10
lncRNA TPTEP1 competitively sponges miR‑328‑5p to inhibit the proliferation of non‑small cell lung cancer cells.lncRNA TPTEP1 通过竞争性吸附 miR-328-5p 抑制非小细胞肺癌细胞的增殖。
Oncol Rep. 2020 May;43(5):1606-1618. doi: 10.3892/or.2020.7522. Epub 2020 Feb 26.